3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Conditions
Nasopharyngeal Carcinoma
10
Leukemia, Myeloid, Acute
4
Carcinoma, Non-Small-Cell Lung
4
Nasopharyngeal Neoplasms
3
Lung Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Myelodysplastic Syndromes
2
Turcot syndrome
1
Tongue Neoplasms
1
Thrombocythemia, Essential
1
Rhabdoid Tumor
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Medulloblastoma
1
Lymphoma
1
Locally Advanced Malignant Neoplasm
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Esophagitis
1
Interventions
Chemoradiotherapy
2
Pemetrexed
1
Induction Chemotherapy
1
Cisplatin
1
Capecitabine
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Locally Advanced Malignant Neoplasm
×
Induction Chemotherapy
×
Clear all
NCT03815903
2019-07-18
INDUCTION
Barretos Cancer Hospital
Phase 3
Unknown
434 enrolled